Xenetic Biosciences, Inc. Warrants
XBIOW
XBIOW was delisted on the 16th of July, 2024.
1 hedge funds and large institutions have $3K invested in Xenetic Biosciences, Inc. Warrants in 2021 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.
50% more capital invested
Capital invested by funds: $2K → $3K (+$1K)
0% more funds holding
Funds holding: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.79K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $3K | +$1.79K | +683 | +55% |
|
XBIOW Hedge Fund Activity: Q1 2021 in Review
1 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Xenetic Biosciences, Inc. Warrants (XBIOW) for Q1 2021, worth a combined $3K — up 50% from $2K a quarter earlier.
Fund positioning in XBIOW was balanced in Q1 2021: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $1.79K.
- 1 institutional investor held Xenetic Biosciences, Inc. Warrants (XBIOW) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $3K of Xenetic Biosciences, Inc. Warrants stock for Q1 2021, up 50% quarter-over-quarter.
- 0 funds opened new Xenetic Biosciences, Inc. Warrants positions in Q1 2021 and 0 closed out.
- The largest Xenetic Biosciences, Inc. Warrants buyer in Q1 2021 was UBS Group, an estimated $1.79K added.
Based on aggregated 13F filings for Q1 2021.